Affiliation: University of Copenhagen
- Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic menLisbet Brandi
Nephrological Department P, Rigshospitalet, University of Copenhagen, Denmark
Nephrol Dial Transplant 17:829-42. 2002..The aim of the present study was to evaluate the pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) after oral and i.v. administration in healthy volunteers and uraemic patients...
- Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assaysLisbet Brandi
Nephrological Department P, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Nephron Clin Pract 99:c128-37. 2005....
- 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysisLisbet Brandi
Nephrological Department P, Rigshospitalet, Copenhagen, Denmark
Dan Med Bull 55:186-210. 2008..There is an urgent need for a development of an algorithm for the use of phosphate binders and vitamin D supplementation in combination with calcimimetics focusing upon long term morbidity and mortality in uremic patients...